Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1589-1593

  Ceriello, Antonio ^a   Bortolotti, Nadia ^a   Pirisi, Mario ^a   Crescentini, Adriana ^a   Tonutti, Laura ^b   Motz, Enrico ^a   Russo, Assunta ^a   Giacomello, Roberta ^a   Stel, Giuliana ^a   Taboga, Claudio ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; D DIMER; FIBRINOGEN; FREE RADICAL; PROTHROMBIN; RETINOL; THIOL GROUP; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEMOSTASIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLASMA CHARACTERISTICS; THROMBOSIS;

EID: 0030762232     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1589     Document Type: Article

References (56)

1. Ostermann H, van de Loo J: Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Haemostasis 16:386-416, 1986
2. Ceriello A: Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119-1125, 1993
3. Barrowcliffe TW, Gutteridge JM, Gray E: Oxygen radicals, lipid peroxidation and the coagulation system. Agent Actions 22:347-348, 1987
4. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
5. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
6. Jennings PE, McLaren M, Scott NA, Saniabadi AR, Belch JJF: The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy. Diabet Med 8:860-865, 1991
7. Collier A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M: Free radical activity and, hemostatic factor in NIDDM patients with and without microalbuminuria. Diabetes 41:909-913, 1992
8. Knöbl P, Schernthaner G, Schack C, Pietschnann P, Griesmacher A, Prager R, Müller M: Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
9. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E: Hyperglycaemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Diabetes 44:924-928, 1995
10. Halliwell B, Gutteridge JMC: The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1-8, 1990
11. Oberley LW: Free radicals and diabetes. Free Radic Biol Med 5:113-124, 1988
12. Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH: Serum antioxidant activity in diabetes mellitus. Diabetes Res 7:89-92, 1988
13. Stankova L, Riddle M, Larned J, Burry K, Menashe D, Hart J, Bigley R: Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 33:347-353, 1984
14. Karpen CW, Cataland S, O'Dorisio T, Panganamala R: Interrelation of platelet vitamin E and thromboxane synthesis in type I diabetes mellitus. Diabetes 33:239-243, 1984
15. Strain JJ: Disturbances of micronutrients and antioxidant status in diabetes. Proc Nutr Soc 50:591-604, 1991
16. Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, Kato K, Nakazawa S: Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 15:597-602, 1993
17. Basu TK, Tze WJ, Leichter J: Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 50:329-331, 1989
18. Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A: A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic Biol Med 18:29-36, 1995
19. Ceriello A, Bortolotti N, Falleti E, Taboga C, Tonutti L, Crescentini A, Motz E, Lizzio S, Russo A, Bartoli E: Total radical-trapping antioxidant parameter in non-insulin dependent diabetic patients. Diabetes Care 20:194-197, 1997
20. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993
21. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR: Diabetes, fibrinogen and risk of cardiovascular disease: the Framingham experience. Am Heart J 120:672-676, 1990
22. Ceriello A: Fibrinogen and diabetes mellitus: is it time for interventional trials? Diabetologia 40:731-734, 1997
23. Aronson DL, Stevan L, Ball AP, Franza BR Jr., Finlayson JS: Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma. J Clin Invest 60:1410-1418, 1977
24. Graeff H, Hafter R: Detection and relevance of cross linked fibrin derivatives in blood. Sem Thromb Hemost 8:57-68, 1982
25. Ceriello A, Giacomello R, Colatutto A, Taboga C, Gonano F: Increased prothrombin fragment 1+2 in type I diabetic patients. Haemostasis 22:50-51, 1992
26. Myrupp B, Rossing P, Jensen T, Gram J, Kluft C, Jespersen J: Procoagulant activity and intimal dysfunction in IDDM. Diabetologia 38:73-78, 1995
27. Van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR: Coagulation activation in diabetes mellitus. Haemostasis 20:263-269, 1990
28. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1037-1057, 1979
29. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L: A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453-469, 1986
30. Mares-Perlman JA, Klein BEK, Klein R, Ritter LL, Fisher MR, Freudenheim JL: A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr 123:489-501, 1993
31. Mallia AK, Heremenson GT, Krohn RS, Fujimoto EK, Smith PK: Preparation and use of a boronic acid affinity chromatography for separation and quantification of glycosylated hemoglobin. Analyt Lett 14:649-661, 1981
32. Tsan ZL, Chin N, Kiser MD, Bigler WN: Specific spectrophotometry of ascorbic acid in serum or plasma by use of ascorbate oxidase. Clin Chem 28:2225-2228, 1982
33. McCormick DB, Wright LD (Eds.): Vitamins and coenzymes, part F. In Methods in Enzymology. Vol. 67. New York, Academic, 1980
34. Koster JF, Biemond P, Swaak AJ: Intracellular and extracellular sulphydryl levels in rheumatoid arthitis. Ann Rheum Dis 45:44-46, 1986
35. Rossi E, Lombardi A, Preda L: Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 52:453-468, 1988
36. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment F1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 65:153-159, 1991
37. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesden G: An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767-778, 1983
38. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 52:591-611, 1965
39. Altman DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1991, p. 340-344
40. Dixon WJ: BMDP Statistical Software Manual. Berkeley, CA, University of California Press, 1992, p. 387-425.
41. Blanchard P, Anton B, Larousse C, Auget D, Mainard F, Charbonnel B, Krempf M: Plasma vitamin E, non-high density lipoprotein cholesterol, and apolipoprotein B in diabetic patients. Clin Chem 38:2339-2340, 1992
42. Colwell JA: Vascular thrombosis in type II diabetes mellitus. Diabetes 42:8-11, 1993
43. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetes in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1974
44. Theroux P, Latour JG, Leger-Gauthier C, De Lara J: Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 75:156-162, 1987
45. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE: Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 317:1361-1365, 1987
46. Siemens A, Giannitsis E, Brueckner S, Mitusch R, Schmuecker G, Sheikzadeh A, Diederich KW, Wagner T: Severe coronary artery disease proves to be associated with increased levels of prothrombin fragments 1+2 (Abstract). Thromb Haemostas 73: A215, 1995
47. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ: Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90:2236-2240, 1994
48. Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz E, Lizzio S, Gonano F, Bartoli E: Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes 43:430-432, 1994
49. Riemersa RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337:1-5, 1991
50. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449, 1993
51. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 328:1450-1456, 1993
52. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011, 1993
53. Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ: The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochem Biophys Acta 924:408-419, 1987
54. Boeri D, Almus FE, Maiello M, Cagliero E, Rao LVM, Lorenzi M: Modification of tissue factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured endothelial cells. Diabetes 38:212-218, 1989
55. Tesfamariam B: Free radicals and diabetic endothelial dysfunction. Free Radic Biol Med 16:383-391, 1994
56. Ceriello A, Curcio F, Dello Russo P, Pegoraro I, Stel G, Amstad P, Cerutti P: The defense against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coag Fibrinolysis 6:133-137, 1995